We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

19 hedge funds and large institutions have $1.61M invested in Dare Bioscience in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

102% more capital invested

Capital invested by funds: $801K → $1.61M (+$813K)

0.19% more ownership

Funds ownership: 0.32% → 0.51% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 21 → 19 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$461K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$136K
3
FFS
Founders Financial Securities
Maryland
+$79.1K
4
Northern Trust
Northern Trust
Illinois
+$31.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$13.7K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$38.8K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17K
3
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$7.65K
4
Victory Capital Management
Victory Capital Management
Texas
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$645K +$461K +37,589 +224%
PVMCV
2
Polaris Venture Management Co V
Massachusetts
$323K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$240K +$136K +11,057 +121%
FFS
4
Founders Financial Securities
Maryland
$102K +$79.1K +6,458 +387%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$87K – – –
IVM
6
InterWest Venture Management
California
$50K – – –
Northern Trust
7
Northern Trust
Illinois
$50K +$31.2K +2,547 +153%
VF
8
Virtu Financial
New York
$41K +$42.2K +3,443 New
HighTower Advisors
9
HighTower Advisors
Illinois
$26K +$10.2K +834 +62%
ECM
10
ETrade Capital Management
Virginia
$15K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$13K +$13.7K +1,118 New
UCFA
12
United Capital Financial Advisors
Texas
$12K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$6K – – –
EWM
14
Edge Wealth Management
New York
$3K – – –
BlackRock
15
BlackRock
New York
$1K – – –
AWA
16
Artemis Wealth Advisors
New York
$871 – – –
UBS Group
17
UBS Group
Switzerland
– -$38.8K -3,167 -99%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$17K -1,709 Closed
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$7.65K -750 Closed
Victory Capital Management
20
Victory Capital Management
Texas
– -$6K -637 Closed

DARE Hedge Fund Activity: Q2 2020 in Review

19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2020, worth a combined $1.61M — up 102% from $801K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DARE and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $461K. The largest seller was UBS Group, cutting an estimated $38.8K.

  • 19 institutional investors held Dare Bioscience (DARE) as of Q2 2020, down from 21 in Q1 2020.
  • Funds reported $1.61M of Dare Bioscience stock for Q2 2020, up 102% quarter-over-quarter.
  • 2 funds opened new Dare Bioscience positions in Q2 2020 and 4 closed out, a net change of -2 holders.
  • The largest Dare Bioscience buyer in Q2 2020 was Renaissance Technologies, an estimated $461K added.
  • The largest Dare Bioscience seller in Q2 2020 was UBS Group, an estimated $38.8K sold.

Based on aggregated 13F filings for Q2 2020.